VIENNA — Lexogen, a specialist in RNA sequencing technologies and next-generation sequencing services, announces the availability of designated NGS service workflows operated in compliance with the principles of the World Health Organization’s Good Clinical Laboratory Practice guidance. The offering is designed for clinical research and clinical-trial projects requiring enhanced controls for sample traceability, documentation, data integrity, technical review, and record retention. For […]
Current Director Dr. Martin Madaus Appointed Interim CEO Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or “the Company”) today announced that current member of the Board of Directors (the “Board”) Dr. Martin Madaus has been appointed interim President and CEO, and that John […]
Jon Pratt brings more than 25 years of leadership experience, most recently as CEO of Filtration Group and previously at Waters, Beckman Coulter Life Sciences and Pall To assume CEO role on September 1, 2026, succeeding Thierry Bernard QIAGEN reaffirms outlook for the third quarter and full-year 2026; strategic review continues VENLO, Netherlands — QIAGEN […]
This partnership brings Hombrechtikon Systems Engineering AG (HSE•AG)’s eviFluor Duo Fluorometer and eviDense UV Photometer to laboratories across the United States and Canada, with Copia Scientific providing automation, integration, and service expertise to support their implementation. TAUNTON, Mass. — Copia Scientific, a provider of laboratory automation, equipment, integration, and service solutions, today announced a new […]
Life sciences leaders Ramon Felciano and Rickard El Tarzi join board as company scales commercialization of its molecular cell architecture platform STOCKHOLM – Pixelgen Technologies, developer of the first high-throughput platform for mapping molecular cell architecture, today announced it has closed an oversubscribed $15.5 million (approximately SEK 150 million) Series B financing to accelerate global […]
Announcing expansion of capabilities to provide customers with a broader range of DNA synthesis solutions, allowing IDT to complement and extend its market position in minimum residual disease (MRD) and multi-cancer early detection (MCED) research to support high-diversity assays Builds on nearly 40 years of synthesis experience to give customers rapid turnaround of high-diversity oligonucleotides and a […]
Veteran Pharmacogenomics Leader and Former St. Jude CEO to Guide BioSkryb’s Next Phase of Growth DURHAM, N.C. — BioSkryb Genomics, a pioneer in single-cell and ultra-low-input multiomic solutions, today announced that William E. Evans, Pharm.D., has been appointed as Chief Executive Officer. Dr. Evans has served on BioSkryb’s Board of Directors and as Chair of […]
Amsbio has launched a range of synthetic cell mimic products that eliminate the variability, fragility, and operational inefficiency inherent in traditional flow cytometry biological and polystyrene bead controls. Researchers in pharmaceutical companies, biotechnology firms, CRO’s, clinical diagnostics and academic centres have long sought access to mass-produced cell mimics that contain rare biomarkers and are stable over the long […]
The Board of Directors of BICO Group AB today announces the appointment of Anders Fogelberg, currently Chief Commercial Officer, as President and CEO, effective September 1, 2026. The Board of Directors have, in a constructive dialogue together with the current President and CEO, Maria Forss, concluded that the time is right for a leadership change. […]
WASHINGTON — Xylem Inc. (NYSE: XYL), a leading global water solutions company, today announced that Andrea van der Berg has been appointed Executive Vice President and Chief Financial Officer, effective September 1, 2026. She will report to President and Chief Executive Officer Matthew Pine and join Xylem’s Executive Leadership Team. Van der Berg succeeds William […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
